Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 5
2007 7
2008 7
2009 7
2010 6
2011 6
2012 8
2013 9
2014 14
2015 8
2016 9
2017 2
2018 8
2019 12
2020 5
2021 7
2022 7
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Killer immunoglobulin-like receptors and tumor immunity.
Benson DM Jr, Caligiuri MA. Benson DM Jr, et al. Cancer Immunol Res. 2014 Feb;2(2):99-104. doi: 10.1158/2326-6066.CIR-13-0219. Cancer Immunol Res. 2014. PMID: 24592397 Free PMC article. Review.
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m2 versus 200mg/m2 preparative regimens in patients with multiple myeloma.
Sharma N, Benson E, Zhao Q, Nunnelee J, Cottini F, Elder P, Rosko A, Bumma N, Khan A, Umyarova E, Devarakonda S, Efebera YA, Benson DM. Sharma N, et al. Among authors: benson dm. Leuk Lymphoma. 2023 Jul-Aug;64(7):1315-1321. doi: 10.1080/10428194.2023.2213366. Epub 2023 May 18. Leuk Lymphoma. 2023. PMID: 37199099
Checkpoint inhibition in myeloma.
Benson DM Jr. Benson DM Jr. Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):528-533. doi: 10.1182/asheducation-2016.1.528. Hematology Am Soc Hematol Educ Program. 2016. PMID: 27913525 Free PMC article. Review.
Retraction Notice to: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.
Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM. Pichiorri F, et al. Among authors: benson dm. Cancer Cell. 2022 Nov 14;40(11):1441. doi: 10.1016/j.ccell.2022.10.006. Epub 2022 Oct 27. Cancer Cell. 2022. PMID: 36306793 Free PMC article. No abstract available.
Most multiple myeloma patients have low testosterone.
John S, Sharma N, Sborov DW, Williams N, Jones D, Benson DM, Efebera YA, Rosko AE, Vincent J, Hofmeister CC. John S, et al. Among authors: benson dm. Leuk Lymphoma. 2019 Mar;60(3):836-838. doi: 10.1080/10428194.2018.1508664. Epub 2018 Oct 2. Leuk Lymphoma. 2019. PMID: 30277092 Free PMC article. No abstract available.
Ninety-minute daratumumab infusion is safe in multiple myeloma.
Barr H, Dempsey J, Waller A, Huang Y, Williams N, Sharma N, Benson DM, Rosko AE, Efebera YA, Hofmeister CC. Barr H, et al. Among authors: benson dm. Leukemia. 2018 Nov;32(11):2495-2518. doi: 10.1038/s41375-018-0120-2. Epub 2018 Mar 31. Leukemia. 2018. PMID: 29679038 Free PMC article. No abstract available.
Tocilizumab for steroid refractory acute graft-versus-host disease.
Roddy JV, Haverkos BM, McBride A, Leininger KM, Jaglowski S, Penza S, Klisovic R, Blum W, Vasu S, Hofmeister CC, Benson DM, Andritsos LA, Devine SM, Efebera YA. Roddy JV, et al. Among authors: benson dm. Leuk Lymphoma. 2016;57(1):81-5. doi: 10.3109/10428194.2015.1045896. Epub 2015 Jul 3. Leuk Lymphoma. 2016. PMID: 26140610 Free PMC article.
Potential of NK cells in multiple Myeloma therapy.
Khan AM, Devarakonda S, Bumma N, Chaudhry M, Benson DM Jr. Khan AM, et al. Among authors: benson dm jr. Expert Rev Hematol. 2019 Jun;12(6):425-435. doi: 10.1080/17474086.2019.1617128. Epub 2019 May 22. Expert Rev Hematol. 2019. PMID: 31070067
106 results